On December 25, the minimally invasive robot revealed that the Dudao bronchoscopic surgery robot independently developed by the company's subsidiary Shanghai Weihang Robotics Co., Ltd. has recently been officially approved for marketing by the State Drug Administration. So far, the number of minimally invasive robotics products approved for marketing in the field of surgical robots has increased to 7, making it the first and currently the only company in the world to achieve the “commercialization of all racetrack products” of surgical robots.

On December 25, the minimally invasive robot revealed that the Dudao bronchoscopic surgery robot independently developed by the company's subsidiary Shanghai Weihang Robotics Co., Ltd. has recently been officially approved for marketing by the State Drug Administration. So far, the number of minimally invasive robotics products approved for marketing in the field of surgical robots has increased to 7, making it the first and currently the only company in the world to achieve the “commercialization of all racetrack products” of surgical robots.